GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Ajinomoto Co Inc (TSE:2802) » Definitions » Valuation Rank

Ajinomoto Co (TSE:2802) Valuation Rank


View and export this data going back to 1949. Start your Free Trial

What is Ajinomoto Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Ajinomoto Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Ajinomoto Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajinomoto Co Business Description

Traded in Other Exchanges
Address
15-1, Kyobashi 1-chome, Chuo-ku, Tokyo, JPN, 104-8315
Ajinomoto Co Inc is Japan's food company specializing in amino acids and seasonings derived from amino acid fermentation technologies. It also produces processed foods including dry soup mixes, frozen foods, and beverage products. Apart from the consumer business, it is a key supplier of MSG and nucleotides to world-wide food manufacturers including Nestle. The food business represents nearly three fourths of group sales and 80%-plus of profits with nearly two thirds generated overseas. Healthcare and function materials (mainly Ajinomoto build-up film, or ABF), the key growth drivers through 2030, make up the balance of its business portfolio. The nonfood businesses are expected to contribute half of the group profits by 2030, boosted by ABF and CDMO growth.